{"pmid":32303108,"title":"Serological survey of SARS-CoV-2 for experimental, domestic, companion and wild animals excludes intermediate hosts of 35 different species of animals.","text":["Serological survey of SARS-CoV-2 for experimental, domestic, companion and wild animals excludes intermediate hosts of 35 different species of animals.","The pandemic SARS-CoV-2 has been reported in 123 countries with more than 5000 patients died from it. However, the original and intermediate hosts of the virus remain unknown. In this study, 1914 serum samples from 35 animal species were used for detection SARS-CoV-2 specific antibodies using double antigen sandwich ELISA after validating its specificity and sensitivity. The results showed that no SARS-CoV-2 specific antibodies were detected in above samples which excluded the possibility of 35 animal species as intermediate host for SARS-CoV-2. More importantly, companion animals including pet dogs (including one dog the SARS-CoV-2 patient kept and two dogs which had close contact with it) and cats, street dogs and cats also showed serological negative to SARS-CoV-2, which relieved the public concerns for the pets as SARS-CoV-2 carriers.","Transbound Emerg Dis","Deng, Junhua","Jin, Yipeng","Liu, Yuxiu","Sun, Jie","Hao, Liying","Bai, Jingjing","Huang, Tian","Lin, Degui","Jin, Yaping","Tian, Kegong","32303108"],"abstract":["The pandemic SARS-CoV-2 has been reported in 123 countries with more than 5000 patients died from it. However, the original and intermediate hosts of the virus remain unknown. In this study, 1914 serum samples from 35 animal species were used for detection SARS-CoV-2 specific antibodies using double antigen sandwich ELISA after validating its specificity and sensitivity. The results showed that no SARS-CoV-2 specific antibodies were detected in above samples which excluded the possibility of 35 animal species as intermediate host for SARS-CoV-2. More importantly, companion animals including pet dogs (including one dog the SARS-CoV-2 patient kept and two dogs which had close contact with it) and cats, street dogs and cats also showed serological negative to SARS-CoV-2, which relieved the public concerns for the pets as SARS-CoV-2 carriers."],"journal":"Transbound Emerg Dis","authors":["Deng, Junhua","Jin, Yipeng","Liu, Yuxiu","Sun, Jie","Hao, Liying","Bai, Jingjing","Huang, Tian","Lin, Degui","Jin, Yaping","Tian, Kegong"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32303108","week":"202016|Apr 13 - Apr 19","doi":"10.1111/tbed.13577","keywords":["intermediate hosts","sars-cov-2","wild animals"],"source":"PubMed","topics":["Mechanism","Transmission"],"weight":1,"_version_":1664357978708377601,"score":8.233237,"similar":[{"pmid":32269068,"title":"Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2.","text":["Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the infectious disease COVID-19, which was first reported in Wuhan, China in December, 2019. Despite the tremendous efforts to control the disease, COVID-19 has now spread to over 100 countries and caused a global pandemic. SARS-CoV-2 is thought to have originated in bats; however, the intermediate animal sources of the virus are completely unknown. Here, we investigated the susceptibility of ferrets and animals in close contact with humans to SARS-CoV-2. We found that SARS-CoV-2 replicates poorly in dogs, pigs, chickens, and ducks, but ferrets and cats are permissive to infection. We found experimentally that cats are susceptible to airborne infection. Our study provides important insights into the animal models for SARS-CoV-2 and animal management for COVID-19 control.","Science","Shi, Jianzhong","Wen, Zhiyuan","Zhong, Gongxun","Yang, Huanliang","Wang, Chong","Huang, Baoying","Liu, Renqiang","He, Xijun","Shuai, Lei","Sun, Ziruo","Zhao, Yubo","Liu, Peipei","Liang, Libin","Cui, Pengfei","Wang, Jinliang","Zhang, Xianfeng","Guan, Yuntao","Tan, Wenjie","Wu, Guizhen","Chen, Hualan","Bu, Zhigao","32269068"],"abstract":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the infectious disease COVID-19, which was first reported in Wuhan, China in December, 2019. Despite the tremendous efforts to control the disease, COVID-19 has now spread to over 100 countries and caused a global pandemic. SARS-CoV-2 is thought to have originated in bats; however, the intermediate animal sources of the virus are completely unknown. Here, we investigated the susceptibility of ferrets and animals in close contact with humans to SARS-CoV-2. We found that SARS-CoV-2 replicates poorly in dogs, pigs, chickens, and ducks, but ferrets and cats are permissive to infection. We found experimentally that cats are susceptible to airborne infection. Our study provides important insights into the animal models for SARS-CoV-2 and animal management for COVID-19 control."],"journal":"Science","authors":["Shi, Jianzhong","Wen, Zhiyuan","Zhong, Gongxun","Yang, Huanliang","Wang, Chong","Huang, Baoying","Liu, Renqiang","He, Xijun","Shuai, Lei","Sun, Ziruo","Zhao, Yubo","Liu, Peipei","Liang, Libin","Cui, Pengfei","Wang, Jinliang","Zhang, Xianfeng","Guan, Yuntao","Tan, Wenjie","Wu, Guizhen","Chen, Hualan","Bu, Zhigao"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32269068","week":"202015|Apr 06 - Apr 12","doi":"10.1126/science.abb7015","source":"PubMed","locations":["China","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission","Prevention"],"weight":1,"_version_":1663620082979307520,"score":306.89093},{"pmid":32201080,"pmcid":"PMC7102515","title":"Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection.","text":["Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection.","SARS-CoV-2 causes the recent global COVID-19 public health emergency. ACE2 is the receptor for both SARS-CoV-2 and SARS-CoV. To predict the potential host range of SARS-CoV-2, we analyzed the key residues of ACE2 for recognizing S protein. We found that most of the selected mammals including pets (dog and cat), pangolin and Circetidae mammals remained the most of key residues for association with S protein from SARS-CoV and SARS-CoV-2. The interaction interface between cat/dog/pangolin/Chinese hamster ACE2 and SARS-CoV/SARS-CoV-2 S protein was simulated through homology modeling. We identified that N82 in ACE2 showed a closer contact with SARS-CoV-2 S protein than M82 in human ACE2. Our finding will provide important insights into the host range of SARS-CoV-2 and a new strategy to design an optimized ACE2 for SARS-CoV-2 infection.","Biochem Biophys Res Commun","Luan, Junwen","Lu, Yue","Jin, Xiaolu","Zhang, Leiliang","32201080"],"abstract":["SARS-CoV-2 causes the recent global COVID-19 public health emergency. ACE2 is the receptor for both SARS-CoV-2 and SARS-CoV. To predict the potential host range of SARS-CoV-2, we analyzed the key residues of ACE2 for recognizing S protein. We found that most of the selected mammals including pets (dog and cat), pangolin and Circetidae mammals remained the most of key residues for association with S protein from SARS-CoV and SARS-CoV-2. The interaction interface between cat/dog/pangolin/Chinese hamster ACE2 and SARS-CoV/SARS-CoV-2 S protein was simulated through homology modeling. We identified that N82 in ACE2 showed a closer contact with SARS-CoV-2 S protein than M82 in human ACE2. Our finding will provide important insights into the host range of SARS-CoV-2 and a new strategy to design an optimized ACE2 for SARS-CoV-2 infection."],"journal":"Biochem Biophys Res Commun","authors":["Luan, Junwen","Lu, Yue","Jin, Xiaolu","Zhang, Leiliang"],"date":"2020-03-24T11:00:00Z","year":2020,"_id":"32201080","week":"202013|Mar 23 - Mar 29","doi":"10.1016/j.bbrc.2020.03.047","keywords":["ACE2","Host range","SARS-CoV-2","Spike protein","Structure"],"source":"PubMed","locations":["N82","Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Transmission"],"weight":1,"_version_":1663352133645238273,"score":282.7223},{"pmid":32104911,"title":"Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.","text":["Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.","To investigate the evolutionary history of the recent outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China, a total of 70 genomes of virus strains from China and elsewhere with sampling dates between 24 December 2019 and 3 February 2020 were analyzed. To explore the potential intermediate animal host of the SARS-CoV-2 virus, we reanalyzed virome data sets from pangolins and representative SARS-related coronaviruses isolates from bats, with particular attention paid to the spike glycoprotein gene. We performed phylogenetic, split network, transmission network, likelihood-mapping, and comparative analyses of the genomes. Based on Bayesian time-scaled phylogenetic analysis using the tip-dating method, we estimated the time to the most recent common ancestor and evolutionary rate of SARS-CoV-2, which ranged from 22 to 24 November 2019 and 1.19 to 1.31 x 10(-3) substitutions per site per year, respectively. Our results also revealed that the BetaCoV/bat/Yunnan/RaTG13/2013 virus was more similar to the SARS-CoV-2 virus than the coronavirus obtained from the two pangolin samples (SRR10168377 and SRR10168378). We also identified a unique peptide (PRRA) insertion in the human SARS-CoV-2 virus, which may be involved in the proteolytic cleavage of the spike protein by cellular proteases, and thus could impact host range and transmissibility. Interestingly, the coronavirus carried by pangolins did not have the RRAR motif. Therefore, we concluded that the human SARS-CoV-2 virus, which is responsible for the recent outbreak of COVID-19, did not come directly from pangolins.","J Med Virol","Li, Xingguang","Zai, Junjie","Zhao, Qiang","Nie, Qing","Li, Yi","Foley, Brian T","Chaillon, Antoine","32104911"],"abstract":["To investigate the evolutionary history of the recent outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China, a total of 70 genomes of virus strains from China and elsewhere with sampling dates between 24 December 2019 and 3 February 2020 were analyzed. To explore the potential intermediate animal host of the SARS-CoV-2 virus, we reanalyzed virome data sets from pangolins and representative SARS-related coronaviruses isolates from bats, with particular attention paid to the spike glycoprotein gene. We performed phylogenetic, split network, transmission network, likelihood-mapping, and comparative analyses of the genomes. Based on Bayesian time-scaled phylogenetic analysis using the tip-dating method, we estimated the time to the most recent common ancestor and evolutionary rate of SARS-CoV-2, which ranged from 22 to 24 November 2019 and 1.19 to 1.31 x 10(-3) substitutions per site per year, respectively. Our results also revealed that the BetaCoV/bat/Yunnan/RaTG13/2013 virus was more similar to the SARS-CoV-2 virus than the coronavirus obtained from the two pangolin samples (SRR10168377 and SRR10168378). We also identified a unique peptide (PRRA) insertion in the human SARS-CoV-2 virus, which may be involved in the proteolytic cleavage of the spike protein by cellular proteases, and thus could impact host range and transmissibility. Interestingly, the coronavirus carried by pangolins did not have the RRAR motif. Therefore, we concluded that the human SARS-CoV-2 virus, which is responsible for the recent outbreak of COVID-19, did not come directly from pangolins."],"journal":"J Med Virol","authors":["Li, Xingguang","Zai, Junjie","Zhao, Qiang","Nie, Qing","Li, Yi","Foley, Brian T","Chaillon, Antoine"],"date":"2020-02-28T11:00:00Z","year":2020,"_id":"32104911","week":"20209|Feb 24 - Mar 01","doi":"10.1002/jmv.25731","keywords":["COVID-19","SARS-CoV-2","TMRCA","cross-species transmission","evolutionary rate","potential intermediate animal host"],"source":"PubMed","locations":["Bayesian","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Transmission"],"weight":1,"_version_":1663352134445301760,"score":180.19554},{"pmid":32194253,"pmcid":"PMC7102648","title":"Molecular basis of COVID-19 relationships in different species: a one health perspective.","text":["Molecular basis of COVID-19 relationships in different species: a one health perspective.","Outside the Hubei province, China, the mild form of infection and the progressive recover of the COVID-19 patients suggest the intervention of \"unconventional\" biological mechanisms worthy of attention. Based on the high-homology between the Spike protein epitopes of taxonomically-related coronaviruses, we hypothesized that past contact with infected dogs shield humans against the circulating SARS-CoV-2. Elseways, the recurrent virus exposure over a short time-lapse might result in the Antibody Dependent Enhancement, triggering the violent immune reaction responsible for the severe clinical outcomes observed in the Hubei province. Nevertheless, further experimental studies are desired for a confidential evaluation of the postulated hypotheses.","Microbes Infect","Tilocca, Bruno","Soggiu, Alessio","Musella, Vincenzo","Britti, Domenico","Sanguinetti, Maurizio","Urbani, Andrea","Roncada, Paola","32194253"],"abstract":["Outside the Hubei province, China, the mild form of infection and the progressive recover of the COVID-19 patients suggest the intervention of \"unconventional\" biological mechanisms worthy of attention. Based on the high-homology between the Spike protein epitopes of taxonomically-related coronaviruses, we hypothesized that past contact with infected dogs shield humans against the circulating SARS-CoV-2. Elseways, the recurrent virus exposure over a short time-lapse might result in the Antibody Dependent Enhancement, triggering the violent immune reaction responsible for the severe clinical outcomes observed in the Hubei province. Nevertheless, further experimental studies are desired for a confidential evaluation of the postulated hypotheses."],"journal":"Microbes Infect","authors":["Tilocca, Bruno","Soggiu, Alessio","Musella, Vincenzo","Britti, Domenico","Sanguinetti, Maurizio","Urbani, Andrea","Roncada, Paola"],"date":"2020-03-21T11:00:00Z","year":2020,"_id":"32194253","week":"202012|Mar 16 - Mar 22","doi":"10.1016/j.micinf.2020.03.002","keywords":["COVID-19","Canine respiratory coronavirus","Coronavirus","Immunization","One health","SARS-CoV-2"],"source":"PubMed","locations":["China","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism"],"weight":1,"_version_":1663352133538283520,"score":165.20422},{"pmid":32302069,"title":"SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup.","text":["SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup.","In late 2019, cases of atypical pneumonia were detected in China. The etiological agent was quickly identified as a betacoronavirus (named SARS-CoV-2), which has since caused a pandemic. Several methods allowing for the specific detection of viral nucleic acids have been established, but these only allow detection of the virus during a short period of time, generally during acute infection. Serological assays are urgently needed to conduct serosurveys, to understand the antibody responses mounted in response to the virus, and to identify individuals who are potentially immune to re-infection. Here we describe a detailed protocol for expression of antigens derived from the spike protein of SARS-CoV-2 that can serve as a substrate for immunological assays, as well as a two-stage serological enzyme-linked immunosorbent assay (ELISA). These assays can be used for research studies and for testing in clinical laboratories. (c) 2020 The Authors. Basic Protocol 1: Mammalian cell transfection and protein purification Basic Protocol 2: A two-stage ELISA for high-throughput screening of human serum samples for antibodies binding to the spike protein of SARS-CoV-2.","Curr Protoc Microbiol","Stadlbauer, Daniel","Amanat, Fatima","Chromikova, Veronika","Jiang, Kaijun","Strohmeier, Shirin","Arunkumar, Guha Asthagiri","Tan, Jessica","Bhavsar, Disha","Capuano, Christina","Kirkpatrick, Ericka","Meade, Philip","Brito, Ruhi Nichalle","Teo, Catherine","McMahon, Meagan","Simon, Viviana","Krammer, Florian","32302069"],"abstract":["In late 2019, cases of atypical pneumonia were detected in China. The etiological agent was quickly identified as a betacoronavirus (named SARS-CoV-2), which has since caused a pandemic. Several methods allowing for the specific detection of viral nucleic acids have been established, but these only allow detection of the virus during a short period of time, generally during acute infection. Serological assays are urgently needed to conduct serosurveys, to understand the antibody responses mounted in response to the virus, and to identify individuals who are potentially immune to re-infection. Here we describe a detailed protocol for expression of antigens derived from the spike protein of SARS-CoV-2 that can serve as a substrate for immunological assays, as well as a two-stage serological enzyme-linked immunosorbent assay (ELISA). These assays can be used for research studies and for testing in clinical laboratories. (c) 2020 The Authors. Basic Protocol 1: Mammalian cell transfection and protein purification Basic Protocol 2: A two-stage ELISA for high-throughput screening of human serum samples for antibodies binding to the spike protein of SARS-CoV-2."],"journal":"Curr Protoc Microbiol","authors":["Stadlbauer, Daniel","Amanat, Fatima","Chromikova, Veronika","Jiang, Kaijun","Strohmeier, Shirin","Arunkumar, Guha Asthagiri","Tan, Jessica","Bhavsar, Disha","Capuano, Christina","Kirkpatrick, Ericka","Meade, Philip","Brito, Ruhi Nichalle","Teo, Catherine","McMahon, Meagan","Simon, Viviana","Krammer, Florian"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32302069","week":"202016|Apr 13 - Apr 19","doi":"10.1002/cpmc.100","keywords":["covid19","elisa","sars-cov-2","protein expression","serological assay"],"source":"PubMed","topics":["Mechanism"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664357978689503232,"score":165.15082}]}